Harry J. De Koning
#140,095
Most Influential Person Now
Harry J. De Koning's AcademicInfluence.com Rankings
Harry J. De Koningmedical Degrees
Medical
#2518
World Rank
#2946
Historical Rank
Epidemiology
#459
World Rank
#481
Historical Rank
Harry J. De Koningphilosophy Degrees
Philosophy
#7282
World Rank
#10474
Historical Rank
Logic
#4340
World Rank
#5621
Historical Rank
Download Badge
Medical Philosophy
Harry J. De Koning's Degrees
- PhD Epidemiology University of Amsterdam
- Doctorate Medicine University of Amsterdam
Why Is Harry J. De Koning Influential?
(Suggest an Edit or Addition)Harry J. De Koning's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Screening and prostate-cancer mortality in a randomized European study. (2009) (3849)
- Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. (2004) (1645)
- Prostate-cancer mortality at 11 years of follow-up. (2012) (1245)
- Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. (2020) (1174)
- Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. (2003) (1104)
- Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context. (2009) (749)
- Management of lung nodules detected by volume CT scanning. (2009) (653)
- Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. (2009) (600)
- Risk‐based selection from the general population in a screening trial: Selection criteria, recruitment and power for the Dutch‐Belgian randomised lung cancer multi‐slice CT screening trial (NELSON) (2007) (524)
- Quality-of-life effects of prostate-specific antigen screening. (2012) (393)
- Overdiagnosis in Mammographic Screening for Breast Cancer in Europe: A Literature Review (2012) (393)
- Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. (2014) (391)
- Benefits and Harms of Computed Tomography Lung Cancer Screening Strategies: A Comparative Modeling Study for the U.S. Preventive Services Task Force (2014) (379)
- European position statement on lung cancer screening. (2017) (372)
- Nodule management protocol of the NELSON randomised lung cancer screening trial. (2006) (332)
- Prostate cancer detection at low prostate specific antigen. (2000) (321)
- Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram. (2006) (305)
- Large‐scale randomized prostate cancer screening trials: Program performances in the European randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trial (2002) (295)
- Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis (2017) (275)
- A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer. (2019) (273)
- Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers. (2014) (257)
- Supplemental MRI Screening for Women with Extremely Dense Breast Tissue. (2019) (245)
- Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer. (2001) (237)
- Breast cancer screening and cost‐effectiveness; Policy alternatives, quality of life considerations and the possible impact of uncertain factors (1991) (232)
- First experiences in screening women at high risk for breast cancer with MR imaging (2000) (222)
- Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial. (2013) (218)
- Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC). (2009) (213)
- Interpreting Overdiagnosis Estimates in Population-based Mammography Screening (2011) (208)
- Scientific Advances in Lung Cancer 2015 (2016) (207)
- Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study (2017) (205)
- Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval (2016) (201)
- Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies (2016) (201)
- Five‐year follow‐up of health‐related quality of life after primary treatment of localized prostate cancer (2005) (197)
- Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial (2013) (185)
- Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012 (2018) (185)
- Short-term effects of population-based screening for prostate cancer on health-related quality of life. (1998) (183)
- Prostate cancer mortality reduction by screening: Power and time frame with complete enrollment in the European randomised screening for prostate cancer (ERSPC) trial (2002) (181)
- Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India. (2008) (181)
- BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study. (2010) (176)
- Anxiety and depression after prostate cancer diagnosis and treatment: 5-year follow-up (2006) (174)
- Benefits, Harms, and Cost-Effectiveness of Supplemental Ultrasonography Screening for Women With Dense Breasts (2015) (170)
- Decreased rates of advanced breast cancer due to mammography screening in The Netherlands (2004) (169)
- Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial. (2016) (168)
- Impact of Reduced Tobacco Smoking on Lung Cancer Mortality in the United States During 1975–2000 (2012) (161)
- Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials (2017) (159)
- NELSON lung cancer screening study (2011) (153)
- Real-Time Monitoring of Results During First Year of Dutch Colorectal Cancer Screening Program and Optimization by Altering Fecal Immunochemical Test Cut-Off Levels. (2017) (153)
- A model for breast cancer screening (1990) (151)
- Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer (2009) (150)
- Computer-aided detection versus independent double reading of masses on mammograms. (2003) (145)
- Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON) (2009) (145)
- Nation‐wide breast cancer screening in The Netherlands: Results of initial and subsequent screening 1990–1995 (1998) (143)
- Comparing coronary artery calcium and thoracic aorta calcium for prediction of all-cause mortality and cardiovascular events on low-dose non-gated computed tomography in a high-risk population of heavy smokers. (2010) (128)
- Smooth or attached solid indeterminate nodules detected at baseline CT screening in the NELSON study: cancer risk during 1 year of follow-up. (2009) (128)
- Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography. (2014) (123)
- Nationwide breast cancer screening programme fully implemented in The Netherlands. (2001) (118)
- Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality. (2014) (117)
- Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits. (2014) (117)
- Metastatic Prostate Cancer Incidence and Prostate-specific Antigen Testing: New Insights from the European Randomized Study of Screening for Prostate Cancer. (2015) (115)
- Screening for prostate cancer: results of the Rotterdam section of the European randomized study of screening for prostate cancer. (2013) (115)
- Identification of chronic obstructive pulmonary disease in lung cancer screening computed tomographic scans. (2011) (113)
- Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials. (1995) (113)
- Psychosocial predictors of first attendance for organised mammography screening (1999) (113)
- Impact of computed tomography screening for lung cancer on participants in a randomized controlled trial (NELSON trial) (2008) (112)
- Radiation-Induced Breast Cancer Incidence and Mortality From Digital Mammography Screening (2016) (109)
- Effect of recall rate on earlier screen detection of breast cancers based on the Dutch performance indicators. (2005) (108)
- Effects of Systematic Screening and Detection of Child Abuse in Emergency Departments (2012) (108)
- Tipping the Balance of Benefits and Harms to Favor Screening Mammography Starting at Age 40 Years (2012) (104)
- The prostate cancer conundrum revisited (2012) (104)
- Internet-administered adolescent health questionnaires compared with a paper version in a randomized study. (2005) (104)
- European randomized lung cancer screening trials: Post NLST (2013) (102)
- Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition (2006) (102)
- Nation‐wide breast cancer screening in the Netherlands: Support for breast‐cancer mortality reduction (1995) (101)
- Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force. (2021) (99)
- Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada (2017) (98)
- Patients' perceptions of the side-effects of prostate cancer treatment--a qualitative interview study. (2006) (95)
- Work at night and breast cancer--report on evidence-based options for preventive actions. (2012) (94)
- Effective PSA contamination in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer (2003) (94)
- Genome-wide association study of coronary and aortic calcification implicates risk loci for coronary artery disease and myocardial infarction. (2013) (93)
- Comparison of screen detected and clinically diagnosed prostate cancer in the European randomized study of screening for prostate cancer, section rotterdam. (2005) (93)
- Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes. (2016) (91)
- Prostate-specific antigen velocity at low prostate-specific antigen levels as screening tool for prostate cancer: results of second screening round of ERSPC (ROTTERDAM). (2004) (90)
- Limited value of shape, margin and CT density in the discrimination between benign and malignant screen detected solid pulmonary nodules of the NELSON trial. (2008) (89)
- Mammography Screening and Risk of Breast Cancer Death: A Population-Based Case–Control Study (2011) (88)
- MR Imaging as an Additional Screening Modality for the Detection of Breast Cancer in Women Aged 50-75 Years with Extremely Dense Breasts: The DENSE Trial Study Design. (2015) (87)
- Lung cancer screening CT-based prediction of cardiovascular events. (2013) (87)
- Pulmonary nodules detected at lung cancer screening: interobserver variability of semiautomated volume measurements. (2006) (87)
- Is prostate cancer different in black men? Answers from 3 natural history models (2017) (86)
- Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality (2004) (86)
- Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen (2014) (86)
- European randomized study of screening for prostate cancer—The Rotterdam pilot studies (1996) (86)
- Gleason score, age and screening: Modeling dedifferentiation in prostate cancer (2006) (86)
- Changing role of 3 screening modalities in the European randomized study of screening for prostate cancer (Rotterdam) (1999) (85)
- Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review. (2020) (84)
- The MISCAN-Fadia continuous tumor growth model for breast cancer. (2006) (84)
- Towards a close computed tomography monitoring approach for screen detected subsolid pulmonary nodules? (2014) (84)
- Effect of nodule characteristics on variability of semiautomated volume measurements in pulmonary nodules detected in a lung cancer screening program. (2008) (82)
- Rotterdam AMblyopia screening effectiveness study: detection and causes of amblyopia in a large birth cohort. (2010) (81)
- Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC) (2015) (79)
- Differences in Natural History between Breast Cancers in BRCA1 and BRCA2 Mutation Carriers and Effects of MRI Screening-MRISC, MARIBS, and Canadian Studies Combined (2012) (79)
- Impact of colorectal cancer screening on cancer-specific mortality in Europe: A systematic review. (2020) (78)
- Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland. (2009) (77)
- Improving cancer control in the European Union: conclusions from the Lisbon round-table under the Portuguese EU Presidency, 2007. (2008) (77)
- The cost‐effectiveness of breast cancer screening (1989) (77)
- In search of the best upper age limit for breast cancer screening. (1995) (77)
- Automated Coronary Artery Calcification Scoring in Non-Gated Chest CT: Agreement and Reliability (2014) (76)
- Magnetic resonance imaging improves breast screening sensitivity in BRCA mutation carriers age ≥ 50 years: evidence from an individual patient data meta-analysis. (2015) (76)
- European Code against Cancer, 4th Edition: Cancer screening. (2015) (75)
- Impact of screening for breast cancer in high-risk women on health-related quality of life (2004) (75)
- Hereditary breast cancer growth rates and its impact on screening policy. (2005) (75)
- Accuracy of a screening instrument to identify potential child abuse in emergency departments. (2014) (74)
- Independent double reading of screening mammograms in The Netherlands: effect of arbitration following reader disagreements. (2004) (74)
- MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial. (2019) (74)
- Adherence to surveillance guidelines after removal of colorectal adenomas: a large, community-based study (2015) (74)
- Personalizing colonoscopy screening for elderly individuals based on screening history, cancer risk, and comorbidity status could increase cost effectiveness. (2015) (73)
- Impressive time‐related influence of the Dutch screening programme on breast cancer incidence and mortality, 1975‐2006 (2008) (73)
- Psychological distress in women at increased risk for breast cancer: the role of risk perception. (2004) (71)
- Nation-wide data on screening performance during the transition to digital mammography: observations in 6 million screens. (2013) (71)
- Detection of child abuse in emergency departments: a multi-centre study (2011) (71)
- Coronary artery calcium can predict all-cause mortality and cardiovascular events on low-dose CT screening for lung cancer. (2012) (71)
- European randomized study of screening for prostate cancer. Progress report of Antwerp and Rotterdam Pilot studies (1995) (70)
- School-based Internet-tailored fruit and vegetable education combined with brief counselling increases children's awareness of intake levels (2007) (67)
- Response shift due to diagnosis and primary treatment of localized prostate cancer: a then-test and a vignette study (2007) (67)
- Additional double reading of screening mammograms by radiologic technologists: impact on screening performance parameters. (2007) (66)
- Cost effectiveness of shortening screening interval or extending age range of NHS breast screening programme: computer simulation study (1998) (66)
- Race-Specific Impact of Natural History, Mammography Screening, and Adjuvant Treatment on Breast Cancer Mortality Rates in the United States (2010) (65)
- Advanced breast cancer and its prevention by screening. (1992) (65)
- The effectiveness of a computer-tailored smoking cessation intervention for participants in lung cancer screening: a randomised controlled trial. (2012) (65)
- Diagnosis of chronic obstructive pulmonary disease in lung cancer screening Computed Tomography scans: independent contribution of emphysema, air trapping and bronchial wall thickening (2013) (63)
- How cost-effective is breast cancer screening in different EC countries? (1993) (63)
- The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening (2016) (63)
- The value of models in informing resource allocation in colorectal cancer screening: the case of the Netherlands (2015) (62)
- Lead-time in the European Randomised Study of Screening for Prostate Cancer. (2010) (62)
- A Comparative Modeling Analysis of Risk-Based Lung Cancer Screening Strategies (2019) (62)
- Informed participation in a randomised controlled trial of computed tomography screening for lung cancer (2009) (61)
- Mammography benefit in the Canadian National Breast Screening Study‐2: A model evaluation (2004) (61)
- The role of conventional bronchoscopy in the workup of suspicious CT scan screen-detected pulmonary nodules. (2012) (60)
- Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging. (2013) (59)
- Mammography screening in the Netherlands: delay in the diagnosis of breast cancer after breast cancer screening (2004) (59)
- A Cluster-Randomized Trial of Screening for Language Delay in Toddlers: Effects on School Performance and Language Development at Age 8 (2007) (58)
- Lung cancer screening by low-dose spiral computed tomography. (2001) (57)
- What If I Don't Treat My PSA-Detected Prostate Cancer? Answers from Three Natural History Models (2011) (57)
- Passive coping and psychological distress in women adhering to regular breast cancer surveillance (2007) (56)
- Disagreement of diameter and volume measurements for pulmonary nodule size estimation in CT lung cancer screening (2017) (56)
- Internet versus paper mode of health and health behavior questionnaires in elementary schools: asthma and fruit as examples. (2006) (56)
- Radiation risk of mammography related to benefit in screening programmes: a favourable balance? (1998) (55)
- The efficacy of prostate‐specific antigen screening: Impact of key components in the ERSPC and PLCO trials (2018) (55)
- Benefits and harms of mammography screening after age 74 years: model estimates of overdiagnosis. (2015) (54)
- Digital mammography screening: weighing reduced mortality against increased overdiagnosis. (2011) (54)
- MRI screening for breast cancer in women with familial or genetic predisposition: design of the Dutch National Study (MRISC) (2001) (54)
- Does "normal" aging imply urinary, bowel, and erectile dysfunction? A general population survey. (2008) (53)
- Evidence for reducing cancer-specific mortality due to screening for breast cancer in Europe: A systematic review. (2020) (53)
- Prostate-Specific Antigen Screening in the United States vs in the European Randomized Study of Screening for Prostate Cancer–Rotterdam (2010) (53)
- Seventy‐five years is an appropriate upper age limit for population‐based mammography screening (2006) (52)
- Overdiagnosis and overtreatment of breast cancer: Microsimulation modelling estimates based on observed screen and clinical data (2005) (52)
- Risk stratification based on screening history: the NELSON lung cancer screening study (2017) (52)
- Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases (2021) (52)
- Sexual function with localized prostate cancer: active surveillance vs radical therapy (2012) (51)
- Pathologic features of prostate cancer found at population-based screening with a four-year interval. (2001) (51)
- The impact of a breast cancer screening programme on quality‐adjusted life‐years (1991) (51)
- Prediction of the effects and costs of breast‐cancer screening in Germany (1994) (51)
- Facilitators and barriers to screening for child abuse in the emergency department (2012) (50)
- Estimating the Effectiveness of Screening for Scoliosis: A Case-Control Study (2008) (50)
- Prostate cancer diagnosis: the impact on patients' mental health. (2006) (49)
- Comparing Benefits from Many Possible Computed Tomography Lung Cancer Screening Programs: Extrapolating from the National Lung Screening Trial Using Comparative Modeling (2014) (49)
- Prostate specific antigen testing and digital rectal examination before and during a randomized trial of screening for prostate cancer: European randomized study of screening for prostate cancer, Rotterdam. (2000) (48)
- The effect of population‐based mammography screening in Dutch municipalities on breast cancer mortality: 20 years of follow‐up (2017) (47)
- Evaluation of prostate-specific antigen, digital rectal examination and transrectal ultrasonography in population-based screening for prostate cancer: improving the efficiency of early detection. (1997) (47)
- Quantification of coronary artery calcium in nongated CT to predict cardiovascular events in male lung cancer screening participants: results of the NELSON study. (2015) (46)
- Mammographic screening: evidence from randomised controlled trials. (2003) (46)
- Contribution of CT Quantified Emphysema, Air Trapping and Airway Wall Thickness on Pulmonary Function in Male Smokers With and Without COPD (2014) (46)
- Effectiveness of screening for amblyopia and other eye disorders in a prospective birth cohort study (2013) (45)
- Cost-effectiveness of stereotactic large-core needle biopsy for nonpalpable breast lesions compared to open-breast biopsy (2004) (44)
- The Cost-Effectiveness of Prostate Cancer Detection with the Use of Prostate Health Index. (2016) (44)
- Patients' Preferences for Scoliosis Brace Treatment: A Discrete Choice Experiment (2010) (44)
- Recommendations for Implementing Lung Cancer Screening with Low-Dose Computed Tomography in Europe (2020) (44)
- Health‐related quality of life in patients with screen‐detected versus clinically diagnosed prostate cancer preceding primary treatment (2001) (43)
- Low all-cause mortality in the volunteer-based Rotterdam section of the European randomised study of screening for prostate cancer: self-selection bias? (2004) (43)
- Airway wall thickness associated with forced expiratory volume in 1 second decline and development of airflow limitation (2015) (42)
- Measuring disease specific quality of life in localized prostate cancer: The Dutch experience (2003) (42)
- How to deal with incidentally detected pulmonary nodules less than 10mm in size on CT in a healthy person. (2008) (42)
- Delayed diagnosis of breast cancer in women recalled for suspicious screening mammography. (2009) (42)
- Predictors of HPV vaccination uptake: a longitudinal study among parents. (2014) (42)
- Lung cancer screening by spiral CT. What is the optimal target population for screening trials? (2002) (41)
- Role of baseline nodule density and changes in density and nodule features in the discrimination between benign and malignant solid indeterminate pulmonary nodules. (2009) (41)
- Do women make an informed choice about participating in breast cancer screening? A survey among women invited for a first mammography screening examination. (2012) (41)
- A cluster-randomised trial of screening for language disorders in toddlers (2004) (41)
- Identifying the barriers to effective breast, cervical and colorectal cancer screening in thirty one European countries using the Barriers to Effective Screening Tool (BEST). (2018) (40)
- Ethnic differences in participation in prenatal screening for Down syndrome: A register‐based study (2010) (39)
- Cost-effectiveness of low-dose CT screening for lung cancer in a European country with high prevalence of smoking-A modelling study. (2018) (39)
- Multiethnic Exome-Wide Association Study of Subclinical Atherosclerosis (2016) (39)
- Population-based mammography screening below age 50: balancing radiation-induced vs prevented breast cancer deaths (2011) (39)
- High affective risk perception is associated with more lung cancer-specific distress in CT screening for lung cancer. (2008) (39)
- Exploring the course of psychological distress around two successive control visits in women at hereditary risk of breast cancer. (2005) (38)
- Cost‐effectiveness of digital mammography screening before the age of 50 in The Netherlands (2015) (38)
- Advanced prostate cancer: Course, care, and cost implications (1999) (37)
- The effects of population‐based mammography screening starting between age 40 and 50 in the presence of adjuvant systemic therapy (2015) (37)
- Informed decision-making in prenatal screening for Down's syndrome: what knowledge is relevant? (2011) (37)
- How Does Early Detection by Screening Affect Disease Progression? (2011) (37)
- The impact of overdiagnosis on the selection of efficient lung cancer screening strategies (2017) (37)
- Supplemental Breast MRI for Women with Extremely Dense Breasts: Results of the Second Screening Round of the DENSE Trial. (2021) (37)
- Which Strategies Reduce Breast Cancer Mortality Most? (2013) (36)
- Diagnosing non-palpable breast disease: short-term impact on quality of life of large-core needle biopsy versus open breast biopsy. (2002) (36)
- An Accurate Cancer Incidence in Barrett's Esophagus: A Best Estimate Using Published Data and Modeling. (2015) (35)
- New Subsolid Pulmonary Nodules in Lung Cancer Screening: The NELSON Trial (2018) (35)
- Women's acceptance of MRI in breast cancer surveillance because of a familial or genetic predisposition. (2006) (35)
- Screening for cardiovascular disease risk using traditional risk factor assessment or coronary artery calcium scoring: the ROBINSCA trial. (2020) (35)
- The impact on socio‐emotional development and quality of life of language impairment in 8‐year‐old children (2011) (35)
- An educational cartoon accelerates amblyopia therapy and improves compliance, especially among children of immigrants. (2012) (34)
- Accuracy of screening women at familial risk of breast cancer without a known gene mutation: Individual patient data meta-analysis. (2017) (34)
- Screening for scoliosis: do we have indications for effectiveness? (2006) (33)
- Psychological Distress and Breast Self-Examination Frequency in Women at Increased Risk for Hereditary or Familial Breast Cancer (2004) (33)
- Cost-Effectiveness Analysis of Lung Cancer Screening in the United States (2019) (33)
- PSA screening for prostate cancer: the current controversy. (1998) (33)
- Psychological risk factors of incidence of breast cancer: a prospective cohort study in Finland (2005) (33)
- Coronary Artery Calcium Imaging in the ROBINSCA Trial: Rationale, Design, and Technical Background. (2018) (32)
- Influence of lung nodule margin on volume- and diameter-based reader variability in CT lung cancer screening. (2018) (32)
- Discriminating dominant computed tomography phenotypes in smokers without or with mild COPD. (2014) (32)
- Disparities in Receiving Guideline-Concordant Treatment for Lung Cancer in the United States. (2020) (32)
- Bracing Patients with Idiopathic Scoliosis: Design of the Dutch Randomized Controlled Treatment Trial (2008) (31)
- No benefit for consensus double reading at baseline screening for lung cancer with the use of semiautomated volumetry software. (2012) (31)
- The provision of information and informed decision-making on prenatal screening for Down syndrome: a questionnaire- and register-based survey in a non-selected population. (2012) (31)
- Association of Chronic Obstructive Pulmonary Disease and Smoking Status With Bone Density and Vertebral Fractures in Male Lung Cancer Screening Participants (2014) (31)
- Overall and disease-specific survival of patients with screen-detected prostate cancer in the European randomized study of screening for prostate cancer, section Rotterdam. (2007) (31)
- Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening: The NELSON study. (2018) (31)
- Introduction of additional double reading of mammograms by radiographers: effects on a biennial screening programme outcome. (2008) (31)
- Rate of progression of CT-quantified emphysema in male current and ex-smokers: a follow-up study (2013) (30)
- Breast cancer screening halves the risk of breast cancer death: a case-referent study. (2014) (30)
- Pregnancy and liver adenoma management: PALM-study (2012) (29)
- Semi-Automatic Quantification of Subsolid Pulmonary Nodules: Comparison with Manual Measurements (2013) (29)
- Assessment of nationwide cancer-screening programmes. (2000) (28)
- Breast cancer screening in Navarra: interpretation of a high detection rate at the first screening round and a low rate at the second round (1997) (28)
- Cost‐effectiveness of High‐performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening (2017) (28)
- A longer breast carcinoma screening interval for women age older than 65 years? (1999) (28)
- Susceptibility to Chronic Mucus Hypersecretion, a Genome Wide Association Study (2011) (28)
- Overdiagnosis by mammographic screening for breast cancer studied in birth cohorts in The Netherlands (2015) (28)
- Informed decision‐making about the fetal anomaly scan: what knowledge is relevant? (2011) (27)
- Breast cancer screening: Evidence for false reassurance? (2008) (27)
- Summary statement on screening for prostate cancer in Europe (2018) (27)
- Quantification of growth patterns of screen-detected lung cancers: The NELSON study. (2017) (26)
- The potential of breast cancer screening in Europe (2020) (26)
- Side‐effects of treatment for localized prostate cancer: are they valued differently by patients and healthy controls? (2007) (26)
- Novel genes for airway wall thickness identified with combined genome-wide association and expression analyses. (2015) (25)
- Health-related quality of life and cost-effectiveness studies in the European randomised study of screening for prostate cancer and the US Prostate, Lung, Colon and Ovary trial. (2001) (25)
- A model-based prediction of the impact on reduction in mortality by a breast cancer screening programme in the city of Florence, Italy. (1995) (25)
- Have Preferences of Girls Changed Almost 3 Years after the Much Debated Start of the HPV Vaccination Program in the Netherlands? A Discrete Choice Experiment (2014) (25)
- Simulating the Impact of Risk-Based Screening and Treatment on Breast Cancer Outcomes with MISCAN-Fadia (2018) (25)
- Parametric response mapping adds value to current computed tomography biomarkers in diagnosing chronic obstructive pulmonary disease. (2015) (25)
- To be screened or not to be screened? Modeling the consequences of PSA screening for the individual (2012) (24)
- Modeling the impact of population screening on breast cancer mortality in the United States. (2011) (24)
- Cost‐effectiveness of HPV‐based cervical screening based on first year results in the Netherlands: a modelling study (2020) (24)
- Breast cancer screening; cost-effective in practice? (2000) (24)
- Incidence of Interval Colorectal Cancer After Negative Results From First-round Fecal Immunochemical Screening Tests, by Cutoff Value and Participant Sex and Age. (2020) (23)
- Introduction to the Cancer Intervention and Surveillance Modeling Network (CISNET) Breast Cancer Models (2018) (23)
- Evaluation of the colorectal cancer screening Programme in the Basque Country (Spain) and its effectiveness based on the Miscan-colon model (2017) (23)
- Risk of cardiovascular mortality in prostate cancer patients in the Rotterdam randomized screening trial. (2006) (23)
- The International Association Study Lung Cancer (IASLC) Strategic Screening Advisory Committee (SSAC) response to the USPSTF recommendations. (2014) (23)
- Predictive value of pulsed Doppler echocardiography in acute myocardial infarction. (1989) (23)
- Health-related quality of life in adolescents with wheezing attacks. (2007) (23)
- Should we start population screening for prostate cancer? Randomised trials are still needed (2002) (22)
- Modeling Ductal Carcinoma In Situ (DCIS): An Overview of CISNET Model Approaches (2018) (22)
- The Role of the (18)F-Fluorodeoxyglucose-Positron Emission Tomography Scan in the Nederlands Leuvens Longkanker Screenings Onderzoek Lung Cancer Screening Trial (2011) (22)
- Estimating the harms and benefits of prostate cancer screening as used in common practice versus recommended good practice: A microsimulation screening analysis (2016) (22)
- Screening for prostate cancer in the US? Reduce the harms and keep the benefit (2015) (22)
- Lung Cancer Detectability by Test, Histology, Stage, and Gender: Estimates from the NLST and the PLCO Trials (2014) (22)
- Collaborative modeling of the impact of obesity on race-specific breast cancer incidence and mortality (2012) (22)
- Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trial (2012) (22)
- Dissecting the genetics of chronic mucus hypersecretion in smokers with and without COPD (2014) (21)
- Cost-effectiveness and budget impact analyses of a colorectal cancer screening programme in a high adenoma prevalence scenario using MISCAN-Colon microsimulation model (2018) (21)
- Generalisability of the results of the Dutch-Belgian randomised controlled lung cancer CT screening trial (NELSON): does self-selection play a role? (2012) (21)
- Serum Lipid Levels, Body Mass Index, and Their Role in Coronary Artery Calcification: A Polygenic Analysis (2015) (20)
- Personalizing Breast Cancer Screening Based on Polygenic Risk and Family History (2020) (20)
- All‐cause mortality versus cancer‐specific mortality as outcome in cancer screening trials: A review and modeling study (2019) (20)
- Detection and interval cancer rates during the transition from screen-film to digital mammography in population-based screening (2018) (20)
- DNA hypermethylation analysis in sputum of asymptomatic subjects at risk for lung cancer participating in the NELSON trial: argument for maximum screening interval of 2 years (2016) (20)
- Likelihood of early detection of breast cancer in relation to false-positive risk in life-time mammographic screening: population-based cohort study. (2013) (19)
- Including the quality‐of‐life effects in the evaluation of prostate cancer screening: expert opinions revisited? (2003) (19)
- PSA levels and cancer detection rate by centre in the European Randomized Study of Screening for Prostate Cancer. (2010) (19)
- Impact of a cardiovascular disease risk screening result on preventive behaviour in asymptomatic participants of the ROBINSCA trial (2019) (19)
- Reasons for (non)participation in supplemental population-based MRI breast screening for women with extremely dense breasts. (2018) (19)
- Is mass screening for breast cancer cost-effective? (1996) (18)
- Low-dose computed tomography screening for lung cancer: results of the first screening round. (2013) (18)
- The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut‐off level on yield of screening (2019) (18)
- A comparison of parent‐reported wheezing or shortness of breath among infants as assessed by questionnaire and physician‐interview: The Generation R study (2010) (18)
- Lung cancer screening and smoking cessation efforts (2021) (18)
- Impacts of a population-based prostate cancer screening programme on excess total mortality rates in men with prostate cancer: a randomized controlled trial (2013) (18)
- Determinants and outcome of unsuccessful referral after positive screening in a large birth-cohort study of population-based vision screening. (2011) (17)
- Informed decision making does not affect health-related quality of life in lung cancer screening (NELSON trial). (2010) (17)
- Treatment capacity required for full‐scale implementation of lung cancer screening in the United States (2019) (17)
- Modeling the natural history of ductal carcinoma in situ based on population data (2020) (17)
- Blinded and uniform cause of death verification in a lung cancer CT screening trial. (2012) (17)
- Cost-Effectiveness of Magnetic Resonance Imaging Screening for Women With Extremely Dense Breast Tissue (2021) (17)
- Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk. (2020) (17)
- Disease-specific mortality may underestimate the total effect of prostate cancer screening (2010) (17)
- Bone density loss on computed tomography at 3-year follow-up in current compared to former male smokers. (2017) (17)
- Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening study (2018) (16)
- Transition from film to digital mammography: impact for breast cancer screening through the national breast and cervical cancer early detection program. (2015) (16)
- Rotterdam randomized pilot studies of screening for prostate cancer--an overview after 10 years. (2005) (16)
- Mammographic screening in BRCA1 mutation carriers postponed until age 40: Evaluation of benefits, costs and radiation risks using models. (2016) (16)
- Deep Learning for Automatic Calcium Scoring in Population-Based Cardiovascular Screening. (2021) (16)
- Growth of hepatocellular adenoma during pregnancy: a prospective study. (2019) (16)
- Blinded and uniform causes of death verification in cancer screening: a major influence on the outcome of a prostate cancer screening trial? (2010) (16)
- Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer Screening. (2021) (16)
- Computed Tomography Structural Lung Changes in Discordant Airflow Limitation (2013) (15)
- Informing on prenatal screening for Down syndrome prior to conception. An empirical and ethical perspective (2012) (15)
- Does participation to screening unintentionally influence lifestyle behaviour and thus lifestyle-related morbidity? (2010) (15)
- Overdiagnosis in lung cancer screening: why modelling is essential (2015) (15)
- Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants: A Comparative Modeling Analysis. (2022) (15)
- Lung cancer screening: latest developments and unanswered questions. (2016) (15)
- Prognostic value of heart valve calcifications for cardiovascular events in a lung cancer screening population (2015) (15)
- Life expectancy of screen‐detected invasive breast cancer patients compared with women invited to the Nijmegen screening program (2010) (14)
- Personalising lung cancer screening: An overview of risk‐stratification opportunities and challenges (2021) (14)
- Treatment of local–regional prostate cancer detected by PSA screening: benefits and harms according to prognostic factors (2013) (14)
- Assessment of harms, benefits, and cost‐effectiveness of prostate cancer screening: A micro‐simulation study of 230 scenarios (2020) (14)
- The influence of health systems on breast, cervical and colorectal cancer screening: an overview of systematic reviews using health systems and implementation research frameworks (2019) (13)
- Limited contamination in the Dutch-Belgian randomized lung cancer screening trial (NELSON). (2010) (13)
- Prediction of higher mortality reduction for the UK Breast Screening Frequency Trial: a model-based approach on screening intervals (2011) (13)
- Screening for type 2 diabetes in a high-risk population: study design and feasibility of a population-based randomized controlled trial (2012) (13)
- Calibrating Parameters for Microsimulation Disease Models (2016) (13)
- Cost‐effectiveness of surveillance schedules in older adults with non‐muscle‐invasive bladder cancer (2018) (13)
- Results of a health systems approach to identify barriers to population-based cervical and colorectal cancer screening programmes in six European countries. (2018) (12)
- Early detection and counselling intervention of asthma symptoms in preschool children: study design of a cluster randomised controlled trial (2010) (12)
- Peptides from the Variable Region of Specific Antibodies Are Shared among Lung Cancer Patients (2014) (12)
- Test Sensitivity in the European Prostate Cancer Screening Trial: Results from Finland, Sweden, and the Netherlands (2009) (12)
- Cost-effectiveness of Digital Breast Tomosynthesis in Population-based Breast Cancer Screening: A Probabilistic Sensitivity Analysis. (2020) (12)
- Biochemical verification of the self-reported smoking status of screened male smokers of the Dutch-Belgian randomized controlled lung cancer screening trial. (2016) (12)
- The importance of screening for lung cancer (2014) (12)
- Mammography requests in general practice during the introduction of nationwide breast cancer screening, 1988-1995. (1999) (11)
- Comparing CISNET Breast Cancer Incidence and Mortality Predictions to Observed Clinical Trial Results of Mammography Screening from Ages 40 to 49 (2018) (11)
- Implementation of lung cancer screening: what are the main issues? (2021) (11)
- Risk stratification in breast cancer screening: Cost‐effectiveness and harm‐benefit ratios for low‐risk and high‐risk women (2020) (11)
- Raising the Bar for the U.S. Preventive Services Task Force (2014) (11)
- Impact of Cardiovascular Calcifications on the Detrimental Effect of Continued Smoking on Cardiovascular Risk in Male Lung Cancer Screening Participants (2013) (11)
- Diffuse Idiopathic Skeletal Hyperostosis Is Associated with Lower Lung Volumes in Current and Former Smokers. (2016) (10)
- Disease-specific survival of men with prostate cancer detected during the screening interval: results of the European randomized study of screening for prostate cancer-Rotterdam after 11 years of follow-up. (2011) (10)
- When should active surveillance for prostate cancer stop if no progression is detected? (2017) (10)
- Socio-economic inequality of utilization of cancer testing in Europe: A cross-sectional study (2022) (10)
- Modeling in Colorectal Cancer Screening: Assessing External and Predictive Validity of MISCAN-Colon Microsimulation Model Using NORCCAP Trial Results (2018) (10)
- [Effects of the population screening into breast cancer]. (2013) (10)
- Update on screening and early detection of prostate cancer (2004) (10)
- High-pitch versus sequential mode for coronary calcium in individuals with a high heart rate: Potential for dose reduction. (2018) (9)
- A health systems approach to identifying barriers to breast cancer screening programmes. Methodology and application in six European countries. (2018) (9)
- Developing a score chart to improve risk stratification of patients with colorectal adenoma (2016) (9)
- Trends in lung cancer risk and screening eligibility affect overdiagnosis estimates. (2019) (9)
- Impact of cause of death adjudication on the results of the European prostate cancer screening trial (2016) (9)
- New Fissure-attached Nodules in Lung Cancer Screening: A Brief Report from The NELSON Study. (2020) (9)
- Evaluating Parameter Uncertainty in a Simulation Model of Cancer Using Emulators (2019) (8)
- Detecting language problems: accuracy of five language screening instruments in preschool children (2007) (8)
- Immediate and delayed effects of mammographic screening on breast cancer mortality and incidence in birth cohorts (2013) (8)
- Follow-up of CT-derived airway wall thickness: Correcting for changes in inspiration level improves reliability. (2016) (8)
- Do Men and Women Need to Be Screened Differently with Fecal Immunochemical Testing? A Cost-Effectiveness Analysis (2017) (8)
- Plusoptix photoscreener use for paediatric vision screening in Flanders and Iran (2019) (8)
- Effect of screening mammography on breast cancer mortality: Quasi‐experimental evidence from rollout of the Dutch population‐based program with 17‐year follow‐up of a cohort (2019) (8)
- The health impact of human papillomavirus vaccination in the situation of primary human papillomavirus screening: A mathematical modeling study (2018) (8)
- Breast cancer incidence trends in Norway and estimates of overdiagnosis (2017) (8)
- Clinically detected non-aggressive lung cancers: implications for overdiagnosis and overtreatment in lung cancer screening (2018) (7)
- Using Collaborative Simulation Modeling to Develop a Web-Based Tool to Support Policy-Level Decision Making About Breast Cancer Screening Initiation Age (2017) (7)
- Estimating the individual benefit of immediate treatment or active surveillance for prostate cancer after screen‐detection in older (65+) men (2016) (7)
- Selection of eligible participants for screening for lung cancer using primary care data (2021) (7)
- COLONOSCOPY-RELATED MORTALITY IN A FECAL IMMUNOCHEMICAL TEST-BASED COLORECTAL CANCER SCREENING PROGRAM. (2020) (7)
- Trends in mammography 1991-96 and the impact of nationwide screening in The Netherlands. (1999) (7)
- Systematic Review and Meta-Analysis of Community- and Choice-Based Health State Utility Values for Lung Cancer (2020) (7)
- Comparing CISNET Breast Cancer Models Using the Maximum Clinical Incidence Reduction Methodology (2018) (7)
- Trade-Offs Between Harms and Benefits of Different Breast Cancer Screening Intervals Among Low-Risk Women (2021) (7)
- Anticipating the Consequences for the Primary Therapy of Breast Cancer after Introducing Screening: A More Global Picture for Health Care Policy Making (1998) (7)
- Cost-Effectiveness of Neonatal Hearing Screening Programs: A Micro-Simulation Modeling Analysis (2020) (6)
- EU Policy on Lung Cancer CT Screening 2017 (2017) (6)
- The role of modelling in the policy decision making process for cancer screening: example of prostate specific antigen screening. (2019) (6)
- Evaluation of Systematic Assessment of Asthma-Like Symptoms and Tobacco Smoke Exposure in Early Childhood by Well-Child Professionals: A Randomised Trial (2014) (6)
- Comparative effectiveness of prostate cancer screening between the ages of 55 and 69 years followed by active surveillance (2018) (6)
- Quality Monitoring of a FIT-Based Colorectal Cancer Screening Program. (2019) (6)
- The Impact of Design and Performance in Prostate-Specific Antigen Screening: Differences Between ERSPC Centers. (2019) (5)
- Implementation of an Educational Cartoon (“the Patchbook”) and Other Compliance-Enhancing Measures by Orthoptists in Occlusion Treatment of Amblyopia (2016) (5)
- Benefits and Harms of Mammography Screening for Women With Down Syndrome: a Collaborative Modeling Study (2019) (5)
- Survivin Autoantibodies Are Not Elevated in Lung Cancer When Assayed Controlling for Specificity and Smoking Status (2015) (5)
- [Screening for lung cancer in the Netherlands: the role of spiral CT scan]. (2001) (5)
- [The scientific basis for population screening for breast cancer in the Netherlands]. (2002) (4)
- Extending Age Ranges in Breast Cancer Screening in Four European Countries: Model Estimations of Harm-to-Benefit Ratios (2021) (4)
- A comparison of disease specific survival of patients who died of and who had newly diagnosed prostate cancer. (1997) (4)
- The role of pre-invasive disease in overdiagnosis: A microsimulation study comparing mass screening for breast cancer and cervical cancer (2016) (4)
- The EU-TOPIA evaluation tool: An online modelling-based tool for informing breast, cervical, and colorectal cancer screening decisions in Europe (2021) (4)
- Development and Validation of Three Regional Microsimulation Models for Predicting Colorectal Cancer Screening Benefits in Europe (2021) (4)
- Screening for cancers with a good prognosis: The case of testicular germ cell cancer (2021) (4)
- Increased non‐prostate cancer death risk in clinically diagnosed prostate cancer (2012) (4)
- Should Never-Smokers at Increased Risk for Lung Cancer Be Screened? (2015) (4)
- Costs and effects of ultrasonography in the evaluation of palpable breast masses (2004) (4)
- Modeling Strategies to Optimize Cancer Screening in USPTSF Guideline-Noncompliant Women. (2021) (4)
- LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries (2022) (4)
- Reply from authors re: Michael Baum. Screening for prostate cancer: can we learn from the mistakes of the breast screening experience? Eur Urol 2013;64:540-1: screening for prostate cancer: we have learned and are still learning. (2013) (4)
- The optimal HPV-screening protocol in Eastern-Europe: The example of Slovenia. (2020) (4)
- LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries (2022) (4)
- Lung-Cancer Screening and the NELSON Trial. Reply. (2020) (3)
- Uniform and blinded cause of death verification of the NELSON lung cancer screening participants. (2017) (3)
- Socioeconomic differences in participation and diagnostic yield within the Dutch national colorectal cancer screening programme with faecal immunochemical testing (2022) (3)
- Disability-Adjusted Life Years Averted Versus Quality-Adjusted Life Years Gained: A Model Analysis for Breast Cancer Screening. (2021) (3)
- Informed decision-making based on a leaflet in the context of prostate cancer screening. (2019) (3)
- Why improvement in survival of screen-detected cases is not necessarily equivalent to benefit? (2003) (3)
- Uptake of minimally invasive surgery and stereotactic body radiation therapy for early stage non-small cell lung cancer in the USA: an ecological study of secular trends using the National Cancer Database (2020) (3)
- [Screening for breast cancer on basis of individual risk assessment for women ineligible for the national population screening program]. (2001) (3)
- Impacts of a population-based prostate cancer screening programme on excess total mortality rates in men with prostate cancer: a randomized controlled trial. (2013) (3)
- Screening for breast cancer, time to think--and stop? National Evaluation Team for Breast Cancer Screening (NETB) (1995) (3)
- Screening for coronary artery calcium in a high-risk population: the ROBINSCA trial. (2020) (3)
- Experiences, expectations and preferences regarding MRI and mammography as breast cancer screening tools in women at familial risk (2021) (2)
- Cost-effectiveness of colorectal cancer screening in Slovakia (2021) (2)
- Coronary artery calcium scoring in individuals at risk for coronary artery disease: current status and future perspectives. (2020) (2)
- Testing at home--the screening of the future? (2009) (2)
- OA05.04 A Comparison of Stage- and Histology-Specific CT Sensitivity in the NELSON Trial and the NLST (2022) (2)
- Foreword: meeting the challenge of prostate cancer. (2010) (2)
- Cost‐effectiveness of multiparametric magnetic resonance imaging and MRI‐guided biopsy in a population‐based prostate cancer screening setting using a micro‐simulation model (2021) (2)
- Early detection of obstructive coronary artery disease in the asymptomatic high-risk population: objectives and study design of the EARLY-SYNERGY trial. (2022) (2)
- [Efficacy of mass screening for breast cancer; reduced mortality nationally and internationally]. (1990) (2)
- The comparative effectiveness of mpMRI and MRI-guided biopsy vs regular biopsy in a population-based PSA testing: a modeling study (2021) (2)
- Impact of assumptions on future costs, disutility and mortality in cost-effectiveness analysis; a model exploration (2021) (2)
- Bracing patients with adolescent idiopathic scoliosis: design of the first randomised controlled treatment trial (2007) (2)
- Multi-Modality Imaging for Prevention of Coronary Artery Disease and Myocardial Infarction in the General Population: Ready for Prime Time? (2022) (2)
- A choice experiment to identify the most important elements of a successful cancer screening program according to those who research and manage such programs (2018) (2)
- Reply to Koleva-Kolarova et al. (2016) (2)
- Reply: stage distribution of lung cancers detected by computed tomography screening in the NELSON Trial. (2013) (2)
- Finding the optimal mammography screening strategy: A cost‐effectiveness analysis of 920 modelled strategies (2022) (2)
- Lung cancer screening and its continuous risk assessment. (2017) (2)
- The Early Detection of Breast Cancer Using Liquid Biopsies: Model Estimates of the Benefits, Harms, and Costs (2022) (2)
- Cost-Effectiveness Analysis of Lung Cancer Screening in the United States (2020) (1)
- The cost-effectiveness of different visual acuity screening strategies in three European countries: A microsimulation study (2022) (1)
- A validated Screening instrument for Child Abuse and Neglect (SCAN) at the emergency department (2022) (1)
- More on screening mammography. (2011) (1)
- Mammography Screening and Breast Cancer Mortality—Response (2012) (1)
- One-off low-dose CT lung cancer screening in China: an appropriate strategy? (2022) (1)
- Breast cancer screening: its impact on clinical medicine. (1990) (1)
- Response to the letter commenting on 'Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review'. (2020) (1)
- Reply to: Comments on “Finding the optimal mammography screening strategy: A cost‐effectiveness analysis of 920 modeled strategies” (2022) (1)
- Screening for coronary artery calcium in a high-risk population: the ROBINSCA trial. (2021) (1)
- Risk Model–Based Lung Cancer Screening (2023) (1)
- Optimizing screening with faecal immunochemical test for both sexes - Cost-effectiveness analysis from Finland. (2022) (1)
- Changes in use of breast-conserving therapy in years 1978-2000. (1994) (1)
- Overcoming barriers: Modelling the effect of potential future changes of organized breast cancer screening in Italy. (2023) (0)
- Rapid elimination of cervical cancer while maintaining the harms and benefits ratio of cervical cancer screening: a modelling study (2022) (0)
- Cost-effectiveness and budget impact analyses of a colorectal cancer screening programme in a high adenoma prevalence scenario using MISCAN-Colon microsimulation model (2018) (0)
- Modeling the natural history of ductal carcinoma in situ based on population data (2020) (0)
- Interpretation and adherence to the updated risk-stratified guideline for colonoscopy surveillance after polypectomy – a nationwide survey (2020) (0)
- The impact of PLCO control arm contamination on perceived PSA screening efficacy (2012) (0)
- [Published effects of screening in parental and child health care]. (1996) (0)
- Genome-wide study identifies two loci associated with lung function decline in mild to moderate COPD (2012) (0)
- Incidence of interval cancer and detection rate of first screenings are inconsistent (1995) (0)
- Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trial (2012) (0)
- Selective screening for scoliosis. (2006) (0)
- [Informed choice: a challenge for the Dutch national breast cancer screening programme]. (2013) (0)
- Detection and interval cancer rates during the transition from screen-film to digital mammography in population-based screening (2018) (0)
- Evaluation of automated coronary calcium distribution in the Robinsca trial (2021) (0)
- Deep learning for automatic calcium scoring in population based cardiovascular screening (2021) (0)
- Towards improved cancer screening in Europe (2018) (0)
- Racial Disparities in Breast Cancer Mortality—Response (2011) (0)
- [The relationship between health gain and effort in mass screening for breast cancer]. (1997) (0)
- Errors in "family" practice. (2005) (0)
- Correction: Susceptibility to Chronic Mucus Hypersecretion, a Genome Wide Association Study (2015) (0)
- Are Low‐ and Middle‐Income Countries Becoming the Victim of Western Debates About Breast Screening? (2010) (0)
- Correction: Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study (2020) (0)
- Re: Think before you leap (2018) (0)
- Concurrent participation in breast, cervical, and colorectal cancer screening in the Netherlands. (2022) (0)
- Cumulative risks of false positive recall and screen-detected breast cancer after multiple screening examinations. (2023) (0)
- Estimating the Effectiveness of Screening for Scoliosis: In Reply (2008) (0)
- Authors' reply to: “Questionable method for estimating the influence of mammography screening on breast cancer mortality in the Netherlands” (2017) (0)
- Editorial: Social Inequality in Cancer Screening (2022) (0)
- Clarifying Assumptions and Outcomes in Cost-effectiveness Analyses. (2016) (0)
- Should We Screen for Language Delay in Toddlers?: In Reply (2008) (0)
- Optimum Management of Pulmonary Nodules. (2017) (0)
- Distinguishing between CISNET model results versus CISNET models (2018) (0)
- Improved Harm/Benefit Ratio and Cost-effectiveness of Prostate Cancer Screening Using New Technologies. (2022) (0)
This paper list is powered by the following services:
